Relation among left ventricular mass, insulin resistance, and blood pressure in nonobese subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 12, 1998, Pages 4284-4288

  Phillips, Robert A ^a,e   Krakoff, Lawrence R ^a   Dunaif, Andrea ^b   Finegood, Diane T ^c   Gorlin, Richard ^a   Shimabukuro, Seiichi ^d  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c SIMON FRASER UNIVERSITY   (Canada)

^d Hirano General Hospital   (Japan)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; ARTERIAL PRESSURE; ARTICLE; BODY MASS; BORDERLINE HYPERTENSION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE TOLERANCE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; PRIORITY JOURNAL;

EID: 0032452554     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.12.4284     Document Type: Article

References (46)

1. 1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. 1990 Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 322:1561-1566.
2. 2. Verdecchia P, Schillaci G, Borgioni C, et al. 1998 Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation. 97:48-54.
3. 3. Schunkert H, Jahn L, Izumo S, Apstein CS, Lorell BH. 1991 Localization and regulation of c-fos and c-jun protooncogene induction by systolic wall stress in normal and hypertrophied rat hearts. Proc Natl Acad Sci USA. 88:11480-11484.
4. 4. Ganau A, Devereux RB, Pickering TG, et al. 1990 Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation. 81:25-36.
5. 5. Frohlich ED, Tarazi RC. 1979 Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol. 44:959-963.
6. 6. Schunkert H, Hense H-W, Holmer SR, et al. 1994 Association between a deletion polymorphism of the angiotensin converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 330:1634-1638.
7. 7. Lauer MS, Anderson KM, Levy D. 1992 Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol. 19:1:130-134.
8. 8. Levy D, Anderson KM, Savage D, Kannel WB, Christiansen JC, Castelli WP. 1988 Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med. 108:7-13.
9. 9. Manolio TA, Levy D, Garrison RJ, Castelli WP, Kannel WB. 1991 Relation of alcohol intake to left ventricular mass: the Framingham Heart Study. J Am Coll Cardiol. 17:717-721.
10. 10. Schmeider RE, Messerli FH, Garavaglia GE, Nunez BE. 1988 Dietary salt intake: a determinant of cardiac involvement in essential hypertension. Circulation. 78:951-956.
11. 11. McNulty PH, Louard RJ, Deckelbaum LI, Zaret BL, Young LH. 1995 Hyperinsulinemia inhibits myocardial protein degradation in patients with cardiovascular disease and insulin resistance. Circulation. 92:2151-2156.
12. 12. Ferrannini E, Buzzigoli G, Bonadonna R, et al. 1987 Insulin resistance in essential hypertension. N Engl J Med. 317:350-357.
13. 13. Anonymous. 1993 The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 153:154-183.
14. 14. Van Italie TB. 1985 Health implications of overweight and obesity in the United States. Ann Intern Med. 103:983-987.
15. 15. Bergman RN, Prager R, Aage V, Olefsky JM. 1987 Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest. 79:790-800.
16. 16. Prigeon RL, Kahn SE, Porte Jr D. 1994 Reliability of error estimates from the minimal-model: implications for measurements in physiological studies. Am J Physiol. 266:E279-E286.
17. 17. Moore CR, Krakoff LR, Phillips RA. 1997 Confirmation or exclusion of stage I hypertension by ambulatory blood pressure monitoring. Hypertension. 29:1109-1113.
18. 18. Verdecchia P, Porcellati C, Schillaci G, et al. 1994 Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 24:793-801.
19. 19. Jhang JS, Diamond JA, Phillips RA. 1997 Interobserver variability of left ventricular measurements in a population of predominantly obese hypertensives using simultaneously acquired and displayed M-Mode and 2D cine echocardiography. Echocardiography. 13:9-14.
20. 20. Devereux RB, Reichek N. 1977 Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 55:613-618.
21. 21. Lauer MS, Anderson KM, Larson M, Levy D. 1994 A new method for indexing left ventricular mass for differences in body size. Am J Cardiol. 74:487-491.
22. 22. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. 1987 Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab. 65:499-507.
23. 23. Dunaif A, Segal K, Futterweit W, Dobrjanski A. 1989 Profound peripheral insulin resistance, independent of obesity in polycystic ovary syndrome. Diabetes. 38:1165-1174.
24. 24. Lind L, Andersson PE, Andren B, Hanni A, Lithell HO. 1995 Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens. 13:433-438.
25. 25. Sharp SD, Williams RR. 1992 Fasting insulin and left ventricular mass in hypertensives and normotensive controls. Cardiology. 81:207-212.
26. 26. Sasson Z, Rasooly Y, Bhesania T, Rasooly I. 1993 Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation. 88:1431-1436.
27. 27. Ohya Y, Abe I, Fujii K, et al. 1996 Hyperinsulinemia and left ventricular geometry in a work-site population in Japan. Hypertension. 27:729-734.
28. 28. Kamide K, Nagano M, Nakano N, et al. 1996 Insulin resistance and cardiovascular complications in patients with essential hypertension. Am J Hypertens. 9:1165-1171.
29. 29 Marcus R, Krause L, Weder AB, Dominguez-Mejia A, Schork NJ, Julius S. 1994 Sex-specific determinants of increased left ventricular mass in the Tecumseh blood pressure study. Circulation. 90:928-936.
30. 30. Tomiyama H, Doba N, Kushiro T, et al. 1997 The relationship of hyper-insulinemic state to left ventricular hypertrophy, microalbuminuia and physical fitness in borderline and mild hypertension. Am J Hypertens. 10:587-591.
31. 31 Lopes De Faria JB, Jones SL, MacDonald F, Chambers J, Mattock MB, Viberti G. 1992 Sodium-lithium countertransport activity and insulin resistance in normotensive IDDM patients. Diabetes. 41:610-615.
32. 32. Grossman E, Shemesh J, Shamiss A, Thaler M, Carrol J, Rosenthal T. 1992 Left ventricular mass in diabetes-hypertension. Arch Intern Med. 152:1001-1004.
33. 33. Nagano N, Nagano M, Yo Y, et al. 1994 Role of glucose intolerance in cardiac diastolic function in essential hypertension. Hypertension. 23:1002-1005.
34. 34. Costa CHRM, Batista MC, Moises VA, Kohlman NB, Ribeiro AB, Zanella MT. 1995 Serum insulin levels, 24-hour blood pressure profile, and left ventricular mass in nonobese hypertensive patients. Hypertension. 26:1085-1088.
35. 35. Rowe JW, Young JB, Minaker KL, Stevens AL, Palotta J, Landsberg L. 1981 Effects of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 30:219-225.
36. 36. Anderson EA, Balon TW, Hoffman RP, Sinkey CA, Mark AL. 1992 Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension. 19:621-627.
37. 37. Laks MM, Morady F, Swan HJC. 1973 Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog. Chest. 64:75-78.
38. 38. Trimarco B, Ricciardelli B, De Luca N, et al. 1985 Participation of endogenous catecholamines in the regulation of left ventricular mass in progeny of hypertensive parents. Circulation. 72:38-46.
39. 39. Molkentin JD, Lu JR, Antos CL, et al. 1998 A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 93:215-228.
40. 40. Kristal B, Levy R, Farah R, et al. 1998 Hypertension and insulin resistance correlate with intracellular ionized calcium of polymorphonuclear leukocytes [Abstract]. Am J Hypertens. 11:151A.
41. 41. Saad MF, Lillioja S, Nyomba BL, et al. 1991 Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med. 324:733-739.
42. 42. Falkner B. 1993 Characteristics of prehypertension in black children. In: Fray JCS, Douglas JG, eds. Pathophysiology of hypertension in blacks. New York: Oxford University Press; 50-65.
43. 43. Howard G, O'Leary DH, Zaccaro D, et al. 1996 Insulin sensitivity and atherosclerosis. Circulation. 93:1809-1817.
44. 44. Ruige JB, Assendelft WJJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. 1998 Insulin and risk of cardiovascular disease: a meta-analysis. Circulation. 97:996-1001.
45. 45. De Simone G, Devereux RB, Roman MJ, Schlussel Y, Alderman MH, Laragh JH. 1991 Echocardiographic left ventricular mass and electrolyte intake predict arterial hypertension. Ann Intern Med. 114:202-209.
46. 46. Post WS, Larson MG, Levy D. 1994 Cardiac structural precursors of hypertension: the Framingham Heart Study. Circulation. 90:179-185.